[26PS3-pm] Pharmacotherapies (Cancer) 2

[26PS3-pm13] Pharmacogenetic analysis of adverse events with osimertinib in patients with non-small cell lung cancer

○Masaaki Tanda¹, Kazuhiro Yamamoto¹, Tomoki Hori², Hiroki Nishiguchi¹, Miki Yagi¹, Michiko Shimizu¹, Toru Konishi¹, Tomonori Ozaki², Natsue Yoshioka², Motoko Tachihara³, Takefumi Ito⁴, Shigeki Ikushima², Tomohiro Omura¹, Ikuko Yano¹ (1. Department of Pharmacy, Kobe University Hospital., 2. Department of Pharmacy, Nara Prefecture General Medical Center., 3. Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine., 4. Division of Respiratory Medicine, Nara Prefecture General Medical Center.)